INSIGHTS ON LIQUID DOSE MANUFACTURING

• Aseptic Extrusion: Preventing Contamination And Ensuring Product Sterility

  Discover the critical process considerations and custom engineering required to handle temperature-sensitive and high-viscosity pharmaceutical materials.

• Design, Operation, And Automation In Aseptic Filling Systems

  Learn about a modular and compact filling and closing system for flexibility in pharmaceutical manufacturing operations and automated processing of vials, syringes, and cartridges.

• Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance

  Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.

• Part I: Defining The Dye Ingress Operating Window

  Dye ingress testing depends on pressure dynamics that shift with viscosity. Discover how these constraints narrow its operating window and call into question its reliability for high‑risk applications.

• Maintaining Sterility Through Precise Component Design And Manufacture

  2/4/2026

  Prioritizing high-quality component design and manufacturing excellence can mitigate risks, ensure long-term container closure integrity, and avoid the costly delays associated with non-compliance.

• Low Temperature Storage Containment For Vial And Syringe Systems

  6/20/2025

  With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

• 5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes

  5/23/2025

  In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

• EU GMP-Annex 1: Changes, Challenges, And Ready-To-Use Sterile Packaging

  8/27/2024

  Leveraging a pre-sterilized containment solution that meets the requirements of Annex 1 and outsources non-core activities can help prevent contamination and reduce the effort and liability of the CCS.

• Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing

  9/8/2025

  This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.